Advertisement

Topics

Sales of GLP-1 receptor agonists and SGLT-2 Inhibitors exceed $8 billion in across the seven major markets in 2017

11:49 EDT 12 Mar 2018 | thePharmaLetter

During 2017, glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose co-transporter -2 (SGLT-2)…

Original Article: Sales of GLP-1 receptor agonists and SGLT-2 Inhibitors exceed $8 billion in across the seven major markets in 2017

NEXT ARTICLE

More From BioPortfolio on "Sales of GLP-1 receptor agonists and SGLT-2 Inhibitors exceed $8 billion in across the seven major markets in 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...